MiMedx Group, Inc. (MDXG)

NasdaqCM • Currently up 0.01 (+0.21%) in today's trading session

1 member of Congress has disclosed 5 trades in MiMedx Group, Inc. (MDXG) via STOCK Act filings. The most recent disclosure was a sale by Tom Malinowski on 3 June 2019. Aggregate disclosed activity totals roughly $8K in purchases and $130K in sales (midpoint estimates from bracketed disclosure amounts).

MiMedx Group, Inc. is currently trading at $4.70, positioned at 34% of its 52-week range ($3.03 – $7.97).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$4.70
24h Change
+0.01 (+0.21%)
52 Week Range
$3.03–$7.97
View on NASDAQ

MiMedx Group, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for MDXG

Select to highlight on chart
5 transactions
Compliance: 20%
Tom Malinowski3 Jun 201913 Aug 2020SaleStock$15,001 - $50,000N/A
Tom Malinowski30 May 20199 Jul 2021SaleStock$15,001 - $50,000N/A
Tom Malinowski30 May 201930 Jul 2021SaleStock$15,001 - $50,000N/A
Tom Malinowski30 May 201926 Aug 2021SaleStock$15,001 - $50,000N/A
Tom Malinowski21 May 201913 Aug 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$685.07M

Volume

1.64M

Beta

1.42

P/E Ratio

13.82

Fundamentals

EPS

$0.34

Div. Yield

-

Open

$4.64

Day Range

$4.64 – $4.74

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Joseph H. Capper
IPO Date
2008-02-12

MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial f...

Earnings

Next Report

Q3 2026

4 Nov

EPS Est.

$0.00

Rev. Est.

$68.6M

Days Until

20

Recent Quarters

Q2 202629 Jul
EPS$-0.05
Miss 1.0%
Q1 202629 Apr
EPS$-0.05
Beat 28.6%
Q4 202525 Feb
EPS$0.14
Beat 55.6%
Q3 202529 Oct
EPS$0.15
Beat 114.3%
Q2 202530 Jul
EPS$0.10
Beat 66.7%
Q1 202530 Apr
EPS$0.06
Beat 0.0%
Q4 202426 Feb
EPS$0.07
Beat 0.0%
Q3 202430 Oct
EPS$0.05
Beat 25.0%
Q2 202431 Jul
EPS$0.08
Beat 0.0%
Q1 202430 Apr
EPS$0.07
Beat 40.0%
Q4 202328 Feb
EPS$0.32
Beat 300.0%
Q3 202330 Oct
EPS$0.06
Beat 20.0%
Q2 20231 Aug
EPS$-0.00
Beat 77.0%
Q1 20232 May
EPS$-0.06
Beat 33.3%
Q4 202228 Feb
EPS$-0.02
Beat 50.0%
Q3 20222 Nov
EPS$-0.09
Miss 12.5%
Q2 20222 Aug
EPS$-0.11
Miss 83.3%
Q1 20223 May
EPS$-0.11
Miss 10.0%
Q4 202128 Feb
EPS$0.01
Beat 133.3%
Q3 20212 Nov
EPS$-0.04
Beat 50.0%
Q2 20213 Aug
EPS$-0.03
Beat 57.1%
Q1 202128 Apr
EPS$-0.09
Beat 52.6%
Q4 20208 Mar
EPS$-0.17
Miss 240.0%
Q3 20204 Nov
EPS$-0.48
Miss 352.6%
Q2 20204 Aug
EPS$-0.08
Miss 153.3%
Q2 20206 Jul
EPS$-0.04
Miss 128.6%
Q4 201917 Mar
EPS$0.38
Beat 322.2%
Q2 201830 Sept
EPS$-0.00
Q1 201830 Jun
EPS$0.02
Q4 201731 Mar
EPS$0.04
Q3 201731 Dec
EPS$0.31
Q3 201726 Oct
EPS$0.08
Beat 0.0%
Q2 201726 Jul
EPS$0.07
Beat 0.0%
Q1 201728 Apr
EPS$0.07
Beat 0.0%
Q4 201623 Feb
EPS$0.07
Miss 12.5%
Q3 201627 Oct
EPS$0.06
Beat 0.0%
Q2 201626 Jul
EPS$0.05
Miss 28.6%
Q1 201625 Apr
EPS$0.04
Miss 20.0%
Q4 201523 Feb
EPS$0.11
Beat 83.3%
Q3 201529 Oct
EPS$0.06
Beat 0.0%
Q2 201530 Jul
EPS$0.05
Beat 0.0%
Q1 201527 Apr
EPS$0.04
Beat 33.3%
Q4 201426 Feb
EPS$0.03
Beat 0.0%
Q3 201430 Oct
EPS$0.03
Beat 50.0%
Q2 201428 Jul
EPS$-0.00
Beat 63.0%
Q1 201425 Apr
EPS$-0.01
Beat 50.0%
Q4 201326 Feb
EPS$-0.01
Beat 66.7%
Q3 201330 Oct
EPS$-0.00
Miss 132.0%
Q2 201331 Jul
EPS$-0.01
Beat 0.0%
Q1 20131 May
EPS$-0.02
Miss 100.0%
Q4 20127 Mar
EPS$-0.01
Beat 50.0%
Q3 201229 Oct
EPS$-0.05
Q2 201214 Aug
EPS$-0.01
Q1 201214 May
EPS$-0.01
Q4 201129 Mar
EPS$-0.04
Q3 201114 Nov
EPS$-0.02
Q2 20114 Aug
EPS$-0.03
Q1 201110 May
EPS$-0.05
Q1 20112 May
EPS$-0.04
Q3 201015 Nov
EPS$-0.05
Q2 201028 Jul
EPS$-0.04
Q1 201014 May
EPS$-0.06
Q3 200931 Dec
EPS$-0.05
Q3 200916 Nov
EPS$-0.11
Q2 20097 Aug
EPS$-0.04
Q1 200915 Jun
EPS$-0.07
Q4 200823 Feb
EPS$-0.06
Q3 200814 Nov
EPS$-0.10
Q2 200830 Sept
EPS$-810.47
Q2 200814 Aug
EPS$-0.09
Q4 200723 Jan
EPS$-0.00
Q3 20078 Nov
EPS$-0.00
Q2 200713 Aug
EPS$-0.00
Q1 200710 May
EPS$-0.00

No dividend data available for this stock.

Stock Splits

Split History

2 Apr 2008Reverse Split
Ratio647:2000

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about MDXG

Which members of Congress have traded MDXG?
1 member of Congress has disclosed 5 trade in MiMedx Group, Inc. (MDXG) under the STOCK Act: Tom Malinowski.
When was MDXG most recently disclosed by Congress?
The most recent MDXG disclosure was a sale by Tom Malinowski on 3 June 2019.
What is the total disclosed congressional trading volume for MDXG?
Members of Congress have disclosed approximately $8K in MDXG purchases and $130K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in MDXG?
This MDXG page updates as soon as new STOCK Act disclosures are filed for MiMedx Group, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.